Evidence map›Paper›PMID 42835977›Full record

ReviewNAM journal2026

From Reduction to Replacement: Challenges and Proposed Solutions for Animal-Free Safety Assessment of Hydrocarbon UVCB Substances.

Daniela Holland, Louise Camenzuli, Lenny Kamelia, Maria Blanco-Rubio

Abstract readReview
In one paragraph

Review in NAM journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Daniela HollandExxonMobil Petroleum & Chemical BV, Machelen, Belgium.
Louise CamenzuliExxonMobil Petroleum & Chemical BV, Machelen, Belgium.
Lenny KameliaShell Global Solutions International BV, The Hague, The Netherlands.
Maria Blanco-RubioShell Global Solutions International BV, The Hague, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The European Commission (EC) developed a Roadmap to phase out animal testing, with milestones and practical steps across 15 different European chemical legislations (EC 2026). Currently though, the number of animals used for compliance testing in the EU remains high, particularly for high-volume chemicals such as Petroleum Substances, and is expected to increase with the introduction of new hazard classes under Regulation (EC) 1272/2008 (CLP). A reduction in animal testing for these substances can be achieved today by grouping, read-across and composition-activity models leveraging historical data and an in-depth understanding of substance composition and manufacturing processes. However, full replacement with New Approach Methodologies (NAM) remains challenging due to the complexity and physico-chemical properties of hydrocarbon substances from conventional and renewable feedstocks which are UVCB substances (Unknown, Variable composition, Complex reaction products or Biological materials). This manuscript outlines the current efforts to reduce animal testing in environmental and human health assessment of hydrocarbon UVCB and highlights key challenges limiting broader application of

Indexed as

3RChemical Safety AssessmentEU RoadmapNew Approach MethodologiesUVCB

Identifiers

PMID42835977
PMCPMC13636300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.